Weleda AG, the global leader in certified natural skincare and anthroposophic medicines, introduces a renewed brand identity. The logo, corporate design, and overall brand presence have been ...

--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Medicines Agency (EMA ... on innovation in science, trial design, community engagement and health equity.

Topline clinical data of the confirmatory registrational study GLOW2 expected in 1Q 2026. <li /> GLOW2 study design mirrors GLOW1 study, ...

TraceLink, the largest end-to-end digital network platform for intelligent supply chain orchestration, proudly announces Bob Sturim, TraceLink Chief Technology ...

Topline clinical data of the confirmatory registrational study GLOW2 expected in 1Q 2026. GLOW2 study design mirrors GLOW1 study, which met primary endpoint and ...

The Brass Armadillo in Grain Valley has cemented its reputation as the Midwest’s premier destination for everyone from serious collectors to casual browsers to people who simply enjoy wandering ...

Morgan Stanley analyst Judah Frommer assumed coverage of Blueprint Medicines (BPMC) with an Equal Weight rating and price target of $100, down ...

Jefferies analyst Michael Yee initiated coverage of Blueprint Medicines (BPMC) with a Buy rating and $135 price target The firm finds the ...

Wolfe Research initiated coverage on shares of Blueprint Medicines (NASDAQ:BPMC – Free Report) in a report published on ...

Equities researchers at Jefferies Financial Group started coverage on shares of Blueprint Medicines (NASDAQ:BPMC – Get Free ...

Fintel reports that on March 17, 2025, Jefferies initiated coverage of Blueprint Medicines (NasdaqGS:BPMC) with a Buy ...

Fintel reports that on March 7, 2025, Scotiabank initiated coverage of Blueprint Medicines (NasdaqGS:BPMC) with a Sector ...